Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

Articles

The companies will combine expertise on T-cell therapies with two or more binding domains to create novel oncology medications.

Amgen Links with Immatics to Continue Work on Bispecific T-Cell Therapies

The partnership will focus on providing practical information to clients on the development of biologics and vaccines.

CSSi LifeSciences and BioMARC Partner to Accelerate Biologics Manufacture

GEA’s ConsiGma continuous tableting line combined with Siemens’ automation and Sipat data management systems enables continuous manufacturing.

Siemens and GEA Partner to Deliver Solid-Dosage Continuous Manufacturing

Catalent announces a development agreement with JOT to evaluate softgel options for a resveratrol drug candidate.

Catalent to Develop Softgels for Orphan Drug Candidate

Johan Remmelgas is associate principal scientist, manufacturability, Pharmaceutical Technology & Development, AstraZeneca R&D, Gothenburg, Sweden.

Moisture uptake during the end-to-end manufacturing process and supply chain can affect product quality. Simulation tools based on mechanistic models help define storage and handling requirements for oral solid-dosage drugs.

Predicting Moisture Uptake in Solid Dosage Packaging

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

Advances in materials and equipment for pharmaceutical blister packaging protect quality and enhance shelf life.

Blister Packaging Moves Forward

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

FDA plans to advance initiatives for ensuring reliable production of drugs and biologics in 2017.

Drug Quality Key to Innovation and Access

A pilot project, beginning in 2017, will support the development of biosimilars.

EMA Launches Biosimilars Project

Univercells received a grant from the Bill & Melinda Gates Foundation for the development of a vaccine manufacturing platform.

Univercells Receives $12-Million Grant to Develop Vaccine Manufacturing Platform

Oxford Genetics received £1.61 million from Innovate UK to explore computational and synthetic biology approaches for optimized mammalian bioproduction.